QHSLab, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- QHSLab, Inc. (Nasdaq: USAQ) develops and commercializes advanced diagnostic technologies for health monitoring and disease detection. The company offers molecular diagnostic platforms, point-of-care testing kits, and laboratory services focused on infectious diseases, oncology biomarkers, and genetic screening; its proprietary QHS technology enables rapid, high-sensitivity nucleic acid amplification and detection systems branded under the QHSLab suite. QHSLab operates primarily in the diagnostics segment of the healthcare industry, serving clinical laboratories, hospitals, and research institutions across North America and select international markets. Founded in 2012 and headquartered in San Diego, California, the company maintains strategic partnerships with leading biotech firms for assay development. In the past two years, QHSLab completed a significant funding round in Q3 2024, raising $45 million to accelerate commercialization of its next-generation QHS Pro analyzer. The company acquired BioDetect Labs in early 2025, expanding its service offerings into personalized medicine and integrating advanced AI-driven analytics into its diagnostic portfolio. Additionally, QHSLab launched its flagship oncology panel in October 2025, targeting early-stage cancer detection, and announced a strategic alliance with a major pharmaceutical partner for co-developing companion diagnostics. These initiatives mark a shift toward integrated health solutions, including cloud-based data platforms for remote monitoring. No subsidiaries or parent relationships are reported.
QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment
QHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet Improvement
QHSLab (OTCMKTS:USAQ) Stock Price Up 15.3% – Here’s Why
Contrasting QHSLab (OTCMKTS:USAQ) & STERIS (NYSE:STE)
QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt Reduction
QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure
QHSLab (OTCQB:USAQ) Announces Launch of Q-Cog™ to Support Early Detection of Mild Cognitive Impairment and Dementia
QHSLab (OTCQB:USAQ) Completes Repurchase of Legacy Debt, Enhancing Capital Structure, Strengthening Balance Sheet and Reducing Future Dilution
QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health
QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth
QHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025
QHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations Program
QHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial Results
QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth
QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology
QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024